You are here: Welcome » Jaahnavi Dave

This is an old revision of the document!


Jaahnavi Dave

Jaahnavi Dave is a PhD student based in Ottawa, Ontario. She works in the cancer immunotherapy program at the Ottawa Hospital Research Institute.

History

As an undergraduate student at McGill University, Dave participated in BioCanRx's 2018 Summer Studentship Program. She worked in the laboratory of Denis Claude Roy at the Université de Montréal.1) She conducted research on targeted cell therapy funded by BioCanRx.2)

Activities

Research

Dave has published research funded by a Fonds de Recherche de Québec - Santé Schan Ontario Graduate Scholarship.3)

1)
Introducing the winners of BioCanRx’s 2018 Summer Studentships. (2018, April 26). BioCanRx. https://web.archive.org/web/20230316080713/https://biocanrx.com/introducing-winners-biocanrx-2018-summer-studentships
2)
BioCanRx Summer Students Tell All. (2018, September 21). BioCanRx. https://web.archive.org/web/20220429044210/https://biocanrx.com/biocanrx-summer-students-tell
3)
Surendran, A., Jamalkhah, M., Poutou, J., Birtch, R., Lawson, C., Dave, J., Crupi, M. J. F., Mayer, J., Taylor, V., Petryk, J., de Souza, C. T., Moodie, N., Billingsley, J. L., Austin, B., Cormack, N., Blamey, N., Rezaei, R., McCloskey, C. W., Fekete, E. E. F., & Birdi, H. K. (2023). Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1099459
Back to top